Loading...
The estimated lifetime risk for trigger finger is about 3% in the general population and as high as 10% in diabetic patients. Treatment options include observation, splinting, nonsteroidal anti-inflammatory drugs, and corticosteroid injections. In this retrospective review, researchers report long-term outcomes of first-time injections for trigger finger in 366 patients (24% with diabetes) who were followed for 5 to 10 years. Treatment was considered to be successful if patients did not need second injections or surgical trigger-finger release.
Overall, 45% of patients benefited after a single injection. Sex and number of trigger fingers at presentation correlated with treatment success: At 10 years, success rates among patients with single …